50 -6 (56) 2023 — Kuchkorov U.I., NazarovA.I. — COGNITIVE DISORDERS IN PATIENTS WITH INVOLUTIONARY PSYCHOSIS

COGNITIVE DISORDERS IN PATIENTS WITH INVOLUTIONARY PSYCHOSIS

Kuchkorov U.I., Bukhara State Medical Institute named after Abu Ali ibn Sina

NazarovA.I. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The development of psychoses and changes in cognitive functions during the involutionary period are among the main indicators of the presence of pathological changes in the brain. 56 patients with involutional psychosis aged 45-60 years were examined using MMSE, MOCA, FAB tests. The relationship between the occurrence of cognitive disorders, the patient’s education and current activity was determined. With involutional depression, cognitive impairments were clearly observed, the duration and severity were constant, cognitive impairments were clearly observed, and the quality of life was also reduced.

Key words: involutionary psychosis, cognitive disorders, intellect, quality of life, treatment.

First page

297

Last page

303

For citation: Kuchkorov U.I., NazarovA.I. – COGNITIVE DISORDERS IN PATIENTS WITH INVOLUTIONARY PSYCHOSIS //New Day in Medicine 2023 6(56): 297-303 https://newdaymedicine.com/index.php/2023/06/20/l-217/

LIST OF REFERENCES:

  1. Концевой В.А., Медведев А.В. К вопросу о шизофрении и бредовых психозах (сравнительно-возрастное исследование). Психиатрия. (2004) 4(10):35-41.
  2. Лейдерман М.В., Сиденкова А.П. Шизофрения у лиц старших возрастных групп. Нейропсихологические аспекты. Уральский медицинский журнал. (2017) 8:24-27.
  3. Aggarwal A., Kean E. Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a cognitive screening tool in an inpatient rehabilitation setting. Neuroscience and Medicine. (2010) 1(2):39.
  4. Brodaty H. et al. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. The British Journal of Psychiatry. (2003) 183(3):213-219.
  5. Henderson A. S. et al. Psychotic symptoms in the elderly: a prospective study in a population sample. International Journal of Geriatric Psychiatry. (1998) 13(7):484-492.
  6. Kirkpatrick B. et al. Is schizophrenia a syndrome of accelerated aging? Schizophrenia bulletin. (2007) 34(6):1024-1032.
  7. Loewenstein D.A., Czaja S.J., Bowie C.R., Harvey P.D. Age-associated differemces in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. American Journal of Geriatric Psychiatry. (2012) 20:29-40.
  8. Malaspina D., Walsh-Messinger J., Gaebel W., Smith L.M., Gorun A., Prudent V., Antonius D., Trémeau F. Negative symptoms, past and present: a historical perspective and moving to DSM-5. Eur Neuropsychopharmacol. (2014) 24(5):710-724.
  9. Nagao S., Yokota O., Ikeda C., Takeda N., Ishizu H., Kuroda S. et al. Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders // Eur Arch Psychiatry Clin Neurosci. (2014) 264(4):317-331.
  10. Rodriguez R.D., Grinberg L.T. Argyrophilic grain disease: An underestimated tauopathy. Dementia Neuropsychologia. (2015) 9(1):2-8.

file

download